Key result
Higher admission HbA1c is linked to ~56% higher odds of unfavorable ischemic stroke outcomes.
Why the study?
Do higher admission HbA1c levels associate with specific stroke etiologies, lesion locations, and worse functional outcomes in adults with acute ischemic stroke?
Observational (n=13,569)
Yes
Do higher admission HbA1c levels associate with specific stroke etiologies, lesion locations, and worse functional outcomes in adults with acute ischemic stroke?
Odds Ratio: 1.56 (95% CI 1.31–1.85)
Elevated admission HbA1c in acute ischemic stroke is associated with large artery atherosclerosis etiology, brainstem lesions, and worse functional outcomes at discharge.
Background Despite abundant evidence linking hyperglycemia to stroke, its heterogeneous effects across stroke etiologies and lesions remain unclear. We examined the associations between admission glycated hemoglobin (HbA1c) levels and stroke subtypes, lesions, and functional outcomes. Methods Adults with acute ischemic stroke admitted between 2016 and 2020 were analyzed using a Japanese nationwide registry. Patients were grouped by admission HbA1c (<6.0%, 6.0–6.9%, 7.0–7.9%, and ≥ 8.0%). Stroke subtypes were determined using the Trial of Org 10,172 in Acute Stroke Treatment criteria. Lesion was categorized as cerebral cortex, basal ganglia/corona radiata, thalamus, brainstem, or cerebellum. Unfavorable outcome was defined as discharge modified Rankin Scale (mRS) >2 for patients with premorbid mRS ≤2, or higher discharge mRS than premorbid mRS for others. Associations were assessed using multivariable mixed-effects logistic regression analysis. Results Among 13,569 patients, HbA1c was <6.0% in 7001 (51.6%), 6.0–6.9% in 4201 (31.0%), 7.0–7.9% in 1264 (9.3%), and ≥ 8.0% in 1103 (8.1%). Higher HbA1c levels were associated with a greater proportion of large artery atherosclerosis (adjusted OR for HbA1c ≥8.0% vs <6.0%, 1.40; 95% CI, 1.19–1.65) and lower proportion of cardioembolism (0.63; 0.50–0.79). Elevated HbA1c levels were associated with higher prevalence of brainstem lesions (2.35; 1.82–3.02) and lower prevalence of cerebral cortex and basal ganglia/corona radiata lesions, even after adjusting for stroke subtype. Unfavorable outcomes were more common in patients with higher HbA1c levels (overall, 1.56; 1.31–1.85), particularly in those with large artery atherosclerosis and cardioembolism. Conclusions Higher admission HbA1c levels were associated with a higher proportion of large artery atherosclerosis and a lower proportion of cardioembolism, with a higher proportion of brainstem lesions and a lower proportion of cortical and basal ganglia/corona radiata lesions, and with worse functional outcomes.
No takes yet. Share an insight, caveat, or question.
Egashira et al. (2026) conducted an observational in Acute ischemic stroke (n=13,569). Elevated admission glycated hemoglobin (HbA1c) vs. HbA1c <6.0% was evaluated on Unfavorable outcome (discharge mRS >2 for premorbid mRS ≤2, or higher discharge mRS than premorbid mRS) (OR 1.56, 95% CI 1.31-1.85). Higher admission HbA1c levels were associated with increased odds of unfavorable functional outcomes (OR 1.56; 95% CI 1.31-1.85) in patients with acute ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: